Novel nonviral vectors target cellular signaling pathways: Regulated gene expression and reduced toxicity

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 2, 2007, Pages 777-783

  Liu, Feng ^a   Conwell, Christine C ^a   Yuan, Xing ^b   Shollenberger, Lisa M ^a,c   Huang, Leaf ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIINFLAMMATORY AGENT; CAPSAICIN; CELL NUCLEUS RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOSOME; MITOGEN ACTIVATED PROTEIN KINASE; SMALL MOLECULE TRANSPORT AGENT; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUSTAINED RELEASE PREPARATION; TRANSGENE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DNA-BINDING PROTEINS; FATTY ACIDS, MONOUNSATURATED; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; LIGANDS; LIPOSOMES; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; NUCLEAR LOCALIZATION SIGNALS; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSGENES;

EID: 34247269732     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.118117     Document Type: Article

References (24)

1. Dauty E, Remy J, Zuber G, and Behr J (2002) Intracellular delivery of nanometric DNA particles via the folate receptor. Bioconjug Chem 13:831-839.
2. Escriou V, Carriere M, Scherman D, and Wils P (2003) NLS bioconjugates for targeting therapeutic genes to the nucleus. Adv Drug Deliv Rev 55:295-306.
3. Guo X and Szoka FJ (2003) Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Acc Chem Res 36:335-341.
4. Hebert E (2003) Improvement of exogenous DNA nuclear importation by nuclear localization signal-bearing vectors: a promising way for non-viral gene therapy? Biol Cell 95:59-68.
5. Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709-760.
6. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, and Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (Lond) 374:546-549.
7. Liu F, Shollenberger LM, and Huang L (2004) Non-immunostimulatory nonviral vectors. FASEB J 18:1779-1781.
8. Liu F, Song Y, and Liu D (1999) Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6:1258-1266.
9. Maglich JM, Sluder AE, Willson TM, and Moore JT (2003) Beyond the human genome: examples of nuclear receptor analysis in model organisms and potential for drug discovery. Am J Pharmacogenomics 3:345-353.
10. Maruyama K (2002) PEG-immunoliposome. Biosci Rep 22:251-266.
11. Nagy L and Schwabe JW (2004) Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci 29:317-324.
12. Niidome T and Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9:1647-1652.
13. Ogris M, Brunner S, Schuller S, Kircheis R, and Wagner E (1999) PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 6:595-605.
14. Redinger RN (2003) The coming of age of our understanding of the enterohepatic circulation of bile salts. Am J Surg 185:168-172.
15. Schulman I and Heyman R (2004) The flip side: Identifying small molecule regulators of nuclear receptors. Chem Biol 11:639-646.
16. Singh S, Natarajan K, and Aggarwal BB (1996) Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. J Immunol 157:4412-4420.
17. Sonoda J, Rosenfeld JM, Xu L, Evans RM, and Xie W (2003) A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. Curr Drug Metab 4:59-72.
18. Tan Y, Li S, Pitt BR, and Huang L (1999) The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther 10:2153-2161.
19. Wheeler JJ, Palmer L, Ossanlou M, MacLachlan I, Graham RW, Zhang YP, Hope MJ, Scherrer P, and Cullis PR (1999) Stabilized plasmid-lipid particles: construction and characterization. Gene Ther 6:271-281.
20. Xu L, Huang CC, Huang W, Tang WH, Rait A, Yin YZ, Cruz I, Xiang LM, Pirollo KF, and Chang EH (2002) Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 1:337-346.
21. Yoshizumi M, Abe J, Tsuchiya K, Berk BC, and Tamaki T (2003) Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases. J Pharmacol Sci 91:172-176.
22. Zhang G, Budker V, and Wolff JA (1999) High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 10:1735-1737.
23. Zhou HS, Liu DP, and Liang CC (2004) Challenges and strategies: the immune responses in gene therapy. Med Res Rev 24:748-761.
24. Zuber G, Zammut-Italiano L, Dauty E, and Behr J (2003) Targeted gene delivery to cancer cells: directed assembly of nanometric DNA particles coated with folic acid. Angew Chem Int Ed Engl 42:2666-2699.